20 June 2013
Keywords: genentech/alkermes, file, nutropin, depot, after, positive, results
Article | 27 October 1998
After positive results from Phase III trials, Genentech and partnerAlkermes have decided to proceed with filing a registration dossier for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.